Vietnam Pharmaceutical Comprehensive Report

Vietnam Pharmaceutical Comprehensive Report

Updated: April 19,2022
Code: MR-006
Pages: 108

Summary

Currently, there are 198 pharmaceutical factories in the industry that meet GMP standards of the World Health Organization, 11 factories have invested and met the standards of advanced countries such as those of Europe, the US and Japan. Edition, PIC / S. The total market value of the pharmaceutical industry in 2019 is estimated at US $ 6.6 million, the proportion of which is mainly from imported pharmaceuticals.

Although per capita consumption of Vietnam is growing with CAGR (2012-2019) reaching 12.7%. The growth of the market for prescription drugs will exceed that of over-the-counter medicines. The market value of Patent drugs in Vietnam is tending to increase. The World Health Organization WHO has ranked Vietnam on the list of countries with the highest percentage of people using antibiotics and antibiotic resistance in the world. Despite the decline in consumption value in 2017, by 2018, it is estimated that the consumption value of this product group continues to increase sharply.

In general, pharmaceutical production in Q1 / 2020 prospered over the same period last year. In particular, the group with the strongest increase over the same period in 2019 is other unallocated pharmaceutical products reaching 4.7 million kg, up 81.17% over the same period in 2019.

Table of Contents

Abbreviations
Report summary
1. Business environment
1.1. Macroeconomic situation
1.2. Legal framework
1.3. Trade Agreements
2. Pharmaceutical Industry Overview
2.1. Global Pharmaceutical Industry
2.1.1. Production – Consumption
2.1.2. Export – Import
2.1.3. Production and Consumption Situation in major countries
2.1.4. Large Enterprises in the world
2.2. Vietnam Pharmaceutical Industry Overview
2.2.1. History of Vietnam Pharmaceutical Industry
2.2.2. Industry Position
2.2.3. Industry Scale and Feature
2.2.4. Value Chain of Vietnam Pharmaceutical Industry
2.2.5. Raw materials
2.2.6. Production technology
2.2.7. R&D
2.2.8. Production
2.2.9. Consumption
2.2.10. Export – Import
2.2.11. Price movements
2.2.12. Distribution system
2.3. Risks and challenges
2.4. Industry planning
2.5. Driving forces and forecast
3. Enterprise analysis
3.1. Profitability Ratios
3.2. Cost structure
3.3. Asset Management Ratios
3.4. Capital Structure
3.5. Solvency
3.6. Return on Investment
4. Appendix of financial statements
-----